Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 23

Results For "patent"

320 News Found

CerroZone reduces airborne Covid-19 Delta variant by 99.998% in 1.2 seconds
Biotech | March 31, 2022

CerroZone reduces airborne Covid-19 Delta variant by 99.998% in 1.2 seconds

Air purification system achieves Intertek zero ozone certification


X-Chem’s Noor Shaker awarded for achievements in AI for drug discovery
News | March 30, 2022

X-Chem’s Noor Shaker awarded for achievements in AI for drug discovery

Shaker is one of six receiving an individual award, which recognizes people, organizations and products bringing AI to life and applying it to solve real problems


Dysval gets regulatory approval in Japan
Drug Approval | March 29, 2022

Dysval gets regulatory approval in Japan

Tardive dyskinesia (TD) is a movement disorder that is characterized by uncontrollable, abnormal and repetitive movements of the face, torso and/or other body parts, which may be disruptive and negatively impact patients


Aquavit Files IND with USFDA for DTX-021, a new botulinum toxin
Drug Approval | March 25, 2022

Aquavit Files IND with USFDA for DTX-021, a new botulinum toxin

Aquavit will officially unveil the Dermatox and Microtox programs at the Annual American Academy of Dermatology, the world's largest dermatology conference scheduled from March 25-29, 2022, in Boston, MA


Indoco Remedies receives USFDA approval for Lacosamide tablets
Drug Approval | March 22, 2022

Indoco Remedies receives USFDA approval for Lacosamide tablets

According to IQVIA sales data for the period ending January 2022, Vimpat tablets market achieved annual sales of approx. US $ 1.7 billion


Thirty five generic manufacturers sign agreements with MPP for Paxlovid
News | March 18, 2022

Thirty five generic manufacturers sign agreements with MPP for Paxlovid

The Indian companies that have been granted licences are Cipla, Sun Pharma, Laurus Labs, Divis Labs, Glenmark, Cadila, Torrent, Emcure, McLeods, SMS Pharmaceuticals, Strides, Biocon, Aurobindo Pharma, Hetero, Granules, Amneal, MSN, Arene Life Sciences and Viatris


Boston Scientific opens second R&D centre in Pune
News | March 16, 2022

Boston Scientific opens second R&D centre in Pune

The centre will initially employ 170 engineers, bringing the total number of Boston Scientific’s R&D employees in India to more than 300


UST launches new digital patient engagement solution in partnership with Well-Beat
Digitisation | March 15, 2022

UST launches new digital patient engagement solution in partnership with Well-Beat

The new solution, built on patented blockchain technology, dynamically adapts to patients' behaviour patterns to make clinical encounters more effective


Clarivate deals report highlights emerging trends in biopharma deal-making
Biotech | March 14, 2022

Clarivate deals report highlights emerging trends in biopharma deal-making

RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape


USFDA clears Niramai's breast thermography device
News | March 14, 2022

USFDA clears Niramai's breast thermography device

The SMILE-100 System is a breast thermography device that helps healthcare personnel review, measure and analyze thermally significant indications in the breast region